23,338,039
Vote Records
27,979
Companies
11,817
Funds
4,051
Managers

Home › Companies › Globus Medical, Inc. › 2025-2026

Globus Medical, Inc. 2025-2026 Proxy Voting Records

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings and Globus Medical, Inc.’s Form 8-K, filed June 4, 2026 (Item 5.07 on EDGAR). Page generated November 20, 2026.

  • 5Ballot items
  • 579Asset managers, any item
  • 3,350Fund votes
  • June 3, 2026Meeting date

Results at a glance

Meeting of June 3, 2026: 5 items on Globus Medical, Inc.’s Form 8-K, filed June 4, 2026: 2 elected · 3 approved.

Dissent

Notable dissent: 1 equity or compensation plan (23.4% against).

Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore Globus Medical, Inc. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by Globus Medical, Inc.

These tallies are Globus Medical, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 4, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Globus Medical, Inc. — official shareholder meeting results, meeting held June 3, 2026
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Keith W. Pfeil 293,453,432---- 28,120,7756,902,949 91%Elected—
Elect Director: Robert A. Douglas 311,683,904---- 9,890,3036,902,949 97%Elected—
2. Approval of 2021 Equity Incentive Plan Amendment 246,228,53475,266,53879,135 --6,902,949 77%Approved—
3. Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026 327,965,803467,95543,398 --0 99.9%Approved—
4. Approval, on a non-binding, advisory basis, of the 2025 compensation of the Company's named executive officers 316,289,6755,212,94371,589 --6,902,949 98%Approved—

Source: Globus Medical, Inc., Form 8-K, filed with the SEC on June 4, 2026 — read the filing on EDGAR.

How asset managers voted at the Globus Medical, Inc. 2025-2026 meeting

579 asset managers disclosed a vote on at least one Globus Medical, Inc. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.

Elect Director: Keith W. Pfeil

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 5 wordings of this item as funds reported it.

91% Majority: yes · of votes cast

FOR 91%
FOR: 293,453,432WITHHELD: 28,120,775
Details: description as filed, official tally, votes by 138 asset managers

Description as filed by funds: Election of two Class II directors to serve until the 2029 Annual Meeting of Stockholders: Keith W. Pfeil

Globus Medical, Inc.’s own tally for this item (“Elect Director: Keith W. Pfeil”): 293,453,432 for, 28,120,775 withheld, per its Form 8-K filed June 4, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Each of the director nominees listed below were elected by the Company's stockholders at the Annual Meeting to serve a three-year term on the Board.”
Support: 91% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 138 asset managers below reported 37,508,856 for, 8,667,197 withheld, 90 abstained, 133 not voted.

FORWITHHOLD
FOR: 37,508,856ABSTAIN: 90WITHHOLD: 8,667,197NOT VOTED: 133
Largest asset managers voting on “Election of two Class II directors to serve until the 2029 Annual Meeting of Stockholders: Keith W. Pfeil” at Globus Medical, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard10,239,9460 90402,440For
BlackRock6,276,3330 00For
JANUS INVESTMENT FUND4,634,4820 0283,845Mixed
Invesco4,283,9880 098,993For
Fidelity2,103,8820 0539,585Mixed
JPMorgan2,111,1770 00For
Charles Schwab1,234,3530 00For
State Street900,1880 0942For
Capitol Series Trust00 0713,800Withhold
Dimensional00 0709,871Withhold
AllianceBernstein593,9460 00For
Capital Group574,5000 00For
Nationwide565,8040 00For
Bridge Builder Trust24,5920 0504,579Withhold
Equitable429,1200 00For
T. Rowe Price00 0422,338Withhold
BOSTON TRUST WALDEN FUNDS00 0417,462Withhold
WILLIAM BLAIR FUNDS00 0396,204Withhold
John Hancock00 0388,693Withhold
First Trust00 0365,273Withhold
OBERWEIS FUNDS00 0347,900Withhold
GMO00 0327,787Withhold
Jackson National277,0650 017,043Mixed
TOUCHSTONE STRATEGIC TRUST275,5270 00For
Goldman Sachs264,2760 00For

Showing the 25 largest of 138 asset managers. All 138 are in the interactive database (link above).

Elect Director: Robert A. Douglas

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 5 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 311,683,904WITHHELD: 9,890,303
Details: description as filed, official tally, votes by 138 asset managers

Description as filed by funds: Election of two Class II directors to serve until the 2029 Annual Meeting of Stockholders: Robert Douglas

Globus Medical, Inc.’s own tally for this item (“Elect Director: Robert A. Douglas”): 311,683,904 for, 9,890,303 withheld, per its Form 8-K filed June 4, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Each of the director nominees listed below were elected by the Company's stockholders at the Annual Meeting to serve a three-year term on the Board.”
Support: 97% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 138 asset managers below reported 43,020,849 for, 3,155,262 withheld, 32 abstained, 133 not voted.

FOR
FOR: 43,020,849ABSTAIN: 32WITHHOLD: 3,155,262NOT VOTED: 133
Largest asset managers voting on “Election of two Class II directors to serve until the 2029 Annual Meeting of Stockholders: Robert Douglas” at Globus Medical, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard10,642,4430 320For
BlackRock6,276,3330 00For
JANUS INVESTMENT FUND4,918,3270 00For
Invesco4,382,9810 00For
Fidelity975,4870 01,667,980Mixed
JPMorgan2,111,1770 00For
Charles Schwab1,234,3530 00For
State Street22,6110 0878,519Withhold
Capitol Series Trust713,8000 00For
Dimensional709,8710 00For
AllianceBernstein593,9460 00For
Capital Group574,5000 00For
Nationwide565,8040 00For
Bridge Builder Trust529,1710 00For
Equitable429,1200 00For
T. Rowe Price00 0422,338Withhold
BOSTON TRUST WALDEN FUNDS417,4620 00For
WILLIAM BLAIR FUNDS396,2040 00For
John Hancock388,6930 00For
First Trust365,2730 00For
OBERWEIS FUNDS347,9000 00For
GMO327,7870 00For
Jackson National294,1080 00For
TOUCHSTONE STRATEGIC TRUST275,5270 00For
Goldman Sachs264,2760 00For

Showing the 25 largest of 138 asset managers. All 138 are in the interactive database (link above).

Approval of 2021 Equity Incentive Plan Amendment

Official resultCOMPENSATIONReported outcome: Approved

Combines 3 wordings of this item as funds reported it.

77% Approved · of votes cast

FOR 77%AGAINST
FOR: 246,228,534AGAINST: 75,266,538

Prior year: 76.5% for (June 4, 2025 meeting) ▲ 0.1 pts

Details: description as filed, official tally, votes by 139 asset managers

Description as filed by funds: Approval of an amendment to the Globus Medical, Inc. 2021 Equity Incentive Plan to increase the number of authorized shares thereunder by 1,000,000.

Globus Medical, Inc.’s own tally for this item (“2. Approval of 2021 Equity Incentive Plan Amendment”): 246,228,534 for, 75,266,538 against — passed, per its Form 8-K filed June 4, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The Company's stockholders approved the 2021 Equity Incentive Plan Amendment.”
Support: 77% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of Globus Medical, Inc.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Amend Incentive Stock Option Plan” (4 managers, Fund and manager reports combined; may count the same shares twice; no share total shown); “Amend Omnibus Stock Plan” (4 managers, Fund and manager reports combined; may count the same shares twice; no share total shown).

The 139 asset managers below reported 8,051,311 for, 38,046,524 against, 23,014 abstained, 133 not voted.

FORAGAINST
FOR: 8,051,311AGAINST: 38,046,524ABSTAIN: 23,014NOT VOTED: 133
Largest asset managers voting on “Approval of an amendment to the Globus Medical, Inc. 2021 Equity Incentive Plan to increase the number of auth” at Globus Medical, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard24,10510,618,370 00Against
BlackRock06,276,333 00Against
JANUS INVESTMENT FUND4,634,482283,845 00Mixed
Invesco04,382,981 00Against
Fidelity02,643,467 00Against
JPMorgan2,111,1770 00For
Charles Schwab8801,233,473 00Against
State Street21,333879,797 00Against
Capitol Series Trust0713,800 00Against
Dimensional0709,871 00Against
AllianceBernstein0593,946 00Against
Capital Group0574,500 00Against
Nationwide0565,804 00Against
Bridge Builder Trust0529,171 00Against
Equitable142,412286,708 00Mixed
T. Rowe Price0422,338 00Against
BOSTON TRUST WALDEN FUNDS0417,462 00Against
WILLIAM BLAIR FUNDS0396,204 00Against
John Hancock0388,693 00Against
First Trust0365,273 00Against
OBERWEIS FUNDS0347,900 00Against
GMO0327,787 00Against
Jackson National0294,108 00Against
TOUCHSTONE STRATEGIC TRUST275,5270 00For
Goldman Sachs0264,276 00Against

Showing the 25 largest of 139 asset managers. All 139 are in the interactive database (link above).

Approval, on a non-binding, advisory basis, of the 2025 compensation of the Company's named executive officers

Official resultFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 25 wordings of this item as funds reported it.

98% Approved · of votes cast

FOR 98%
FOR: 316,289,675AGAINST: 5,212,943

Prior year: 97.6% for (June 4, 2025 meeting) ▲ 0.8 pts

Details: description as filed, official tally, votes by 578 asset managers

Description as filed by funds: Approval, on a non-binding, advisory basis, of the 2025 compensation of the company's named executive officers (the "Say-on-Pay" Vote).

Globus Medical, Inc.’s own tally for this item (“4. Approval, on a non-binding, advisory basis, of the 2025 compensation of the Company's named executive officers”): 316,289,675 for, 5,212,943 against — passed, per its Form 8-K filed June 4, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The Company's stockholders approved, on a non-binding, advisory basis the 2025 compensation of the Company's named executive officers, as described in the Proxy Statement.”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 136 asset managers voting on “Approval, on a non-binding, advisory basis, of the 2025 compensation of the company's named executive officers” at Globus Medical, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard10,642,46114 00For
BlackRock6,276,3330 00For
JANUS INVESTMENT FUND4,918,3270 00For
Invesco4,283,98898,993 00For
Fidelity2,643,4670 00For
JPMorgan2,111,1770 00For
Charles Schwab1,234,3530 00For
State Street900,674456 00For
Capitol Series Trust713,8000 00For
Dimensional709,8710 00For
AllianceBernstein593,9460 00For
Capital Group574,5000 00For
Nationwide565,8040 00For
Bridge Builder Trust529,1710 00For
Equitable429,1200 00For
T. Rowe Price422,3380 00For
BOSTON TRUST WALDEN FUNDS417,4620 00For
WILLIAM BLAIR FUNDS396,2040 00For
John Hancock388,6930 00For
First Trust365,2730 00For
OBERWEIS FUNDS347,9000 00For
GMO327,7870 00For
Jackson National294,1080 00For
TOUCHSTONE STRATEGIC TRUST275,5270 00For
Goldman Sachs264,2760 00For

Fund voting reports, all 136 managers: 46,042,179 for, 109,110 against, 23,014 abstained, 133 not voted. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 469 asset managers voting on “Approval, on a non-binding, advisory basis, of the 2025 compensation of the company's named executive officers” at Globus Medical, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Janus Henderson14,204,91124,732 00For
BlackRock3,779,73456,084 00For
Invesco3,488,593126,105 00For
State Street3,302,86229,819 00For
GEODE CAPITAL MANAGEMENT, LLC2,105,2360 00For
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC1,844,2820 00For
GENEVA CAPITAL MANAGEMENT LLC1,654,9910 00For
AllianceBernstein1,522,7890 00For
Sculptor Capital LP1,388,5890 00For
GW&K Investment Management, LLC237,0620 00For
Charles Schwab1,249,2040 00For
BNP Paribas Asset Management Holding S.A.01,139,872 00Against
John Hancock1,081,4710 00For
FULLER & THALER ASSET MANAGEMENT, INC.1,038,8860 00For
BANK OF MONTREAL /CAN/963,1590 00For
Vanguard878,7750 00For
Citadel878,5450 00For
Fidelity787,13687,655 00Mixed
Artemis Investment Management LLP787,6530 00For
MELLON INVESTMENTS Corp765,1680 00For
Northern Trust736,17511,554 00For
PARADIGM CAPITAL MANAGEMENT INC/NY738,1980 00For
T. Rowe Price737,5630 00For
BOSTON TRUST WALDEN NATIONAL ASSOCIATION691,6640 00For
Stephens Investment Management Group LLC620,0770 00For

Institutional-manager reports, all 469 managers: 66,163,025 for, 4,066,323 against, 369 abstained, 7,602 not voted, 1,083,696 mixed. Showing the 25 largest; every one is in the interactive database (link above).

Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm…

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 6 wordings of this item as funds reported it.

99.9% Approved · of votes cast

FOR 99.9%
FOR: 327,965,803AGAINST: 467,955

Prior year: 99.8% for (June 4, 2025 meeting) ▲ 0.1 pts

Details: description as filed, official tally, votes by 140 asset managers

Description as filed by funds: Ratification of the appointment of Deloitte & Touche LLP as the company's independent registered public accounting firm for the year ending December 31, 2026.

Globus Medical, Inc.’s own tally for this item (“3. Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026”): 327,965,803 for, 467,955 against — passed, per its Form 8-K filed June 4, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The Company's stockholders approved the ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 140 asset managers below reported 46,171,902 for, 51 against, 23,014 abstained, 133 not voted.

FOR
FOR: 46,171,902AGAINST: 51ABSTAIN: 23,014NOT VOTED: 133
Largest asset managers voting on “Ratification of the appointment of Deloitte & Touche LLP as the company's independent registered public accoun” at Globus Medical, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard10,642,4741 00For
BlackRock6,276,3330 00For
JANUS INVESTMENT FUND4,918,3270 00For
Invesco4,382,9810 00For
Fidelity2,643,4670 00For
JPMorgan2,111,1770 00For
Charles Schwab1,234,3530 00For
State Street901,08050 00For
Capitol Series Trust713,8000 00For
Dimensional709,8710 00For
AllianceBernstein593,9460 00For
Capital Group574,5000 00For
Nationwide565,8040 00For
Bridge Builder Trust529,1710 00For
Equitable429,1200 00For
T. Rowe Price422,3380 00For
BOSTON TRUST WALDEN FUNDS417,4620 00For
WILLIAM BLAIR FUNDS396,2040 00For
John Hancock388,6930 00For
First Trust365,2730 00For
OBERWEIS FUNDS347,9000 00For
GMO327,7870 00For
Jackson National294,1080 00For
TOUCHSTONE STRATEGIC TRUST275,5270 00For
Goldman Sachs264,2760 00For

Showing the 25 largest of 140 asset managers. All 140 are in the interactive database (link above).

Largest Globus Medical, Inc. shareholders voting in 2025-2026

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 135,744,626 shares outstanding at the time of that meeting.

Fund voting reports: top Globus Medical, Inc. shareholders by shares voted on “Ratification of the appointment of Deloitte & Touche LLP as the company's independent…”, 2025-2026
#Asset manager % of shares outstanding
1Vanguard 7.84%
2BlackRock 4.62%
3JANUS INVESTMENT FUND 3.62%
4Invesco 3.23%
5Fidelity 1.95%
6JPMorgan 1.56%
7Charles Schwab 0.91%
8State Street 0.66%
9Capitol Series Trust 0.53%
10Dimensional 0.52%
Institutional-manager reports: top Globus Medical, Inc. shareholders by shares voted on “Approval, on a non-binding, advisory basis, of the 2025 compensation of the company's named…”, 2025-2026
#Asset manager % of shares outstanding
1Janus Henderson 10.48%
2BlackRock 2.83%
3Invesco 2.66%
4State Street 2.46%
5GEODE CAPITAL MANAGEMENT, LLC 1.55%
6WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 1.36%
7GENEVA CAPITAL MANAGEMENT LLC 1.22%
8AllianceBernstein 1.12%
9Sculptor Capital LP 1.02%
10GW&K Investment Management, LLC 0.97%

Reported Globus Medical, Inc. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.

Globus Medical, Inc. holdings and ownership disclosed for the 2025-2026 proxy season, with each row’s source and date
HolderShares % outstandingSource, as of
Vanguard Group10,549,455 7.77%Form 13F, quarter ended March 31, 2026
BlackRock10,497,414 7.73%Form 13F, quarter ended March 31, 2026
Janus Henderson Group plc7,029,294 5.18%Proxy statement (DEF 14A), table as of March 31, 2026
Invesco4,316,654 3.18%Form 13F, quarter ended March 31, 2026
State Street3,590,372 2.64%Form 13F, quarter ended March 31, 2026
JPMorgan Chase2,595,308 1.91%Form 13F, quarter ended March 31, 2026
Citadel Advisors2,029,114 1.49%Form 13F, quarter ended March 31, 2026
Dimensional Fund Advisors1,769,897 1.30%Form 13F, quarter ended March 31, 2026
Charles Schwab1,243,615 0.92%Form 13F, quarter ended March 31, 2026
David D. Davidar857,742 0.63%Proxy statement (DEF 14A), table as of March 31, 2026

Percentages above are of 135,744,626 shares outstanding, as reported by Globus Medical, Inc. on its Form 10-Q dated May 5, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this meeting

At Globus Medical, Inc.'s shareholder meeting held June 3, 2026, in the 2025-2026 proxy season, 579 asset managers reported votes on at least one of its 5 ballot items in their SEC Form N-PX filings, covering 3,350 separate fund positions. On the most widely held item on that ballot — Approval, on a non-binding, advisory basis, of the 2025 compensation of the company's named… — Globus Medical, Inc.'s filing reports the proposal as approved, with 98% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Globus Medical, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 4, 2026.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Globus Medical, Inc.’s 10-Q dated May 5, 2026. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.

Globus Medical, Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).

Cite this page

Proxy Votes Now, “Globus Medical (GMED) 2026 Annual Meeting: Shareholder Vote Results”, https://proxyvotesnow.com/company/globus-medical-inc/2026 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.